Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 4Stomach Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Lymphatic Metastasis 1Hypoxia 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1Bile Duct Neoplasms 1

Interventions

pembrolizumab 3Trastuzumab 2Interleukin-12 Subunit p35 2Drug Therapy 2tivozanib 1tipifarnib 1spartalizumab 1seribantumab 1pertuzumab 1motexafin lutetium 1irinotecan sucrosofate 1entinostat 1atezolizumab 1Specimen Handling 1Ritonavir 1Quality of Life 1Positron Emission Tomography Computed Tomography 1Peripheral Blood Stem Cell Transplantation 1Patient Reported Outcome Measures 1Paclitaxel 1Oxaliplatin 1Ondansetron 1Octreotide 1Observation 1Nivolumab 1Molecular Diagnostic Techniques 1Mesna 1Magnetic Resonance Spectroscopy 1Leucovorin 1Itraconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bile Duct Neoplasms × Positron Emission Tomography Computed Tomography × Gynecologic × Clear all
NCT05172310 2021-12-29

PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI

Karolinska University Hospital

Phase 1 Recruiting
410 enrolled
GastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Bile Duct Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡